Table 1:

Demographic characteristics of patients with incident end-stage renal disease by ethnicity

CharacteristicNo. of patients (%)p value*
AboriginalWhite
Children and young adults (Incident)n = 159n = 821
Female sex97 (61.0)381 (46.4)0.001
Age at start of renal replacement therapy, yr
 0 to < 516 (10.1)88 (10.7)0.94
 5 to < 1016 (10.1)91 (11.1)
 10 to < 1537 (23.3)179 (21.8)
 15 to < 1835 (22.0)163 (19.9)
 18 to < 2255 (34.6)300 (36.5)
Adults (75% sample)n = 1 113n = 19 363
Female sex591 (53.1)7 570 (39.1)< 0.001
Age at start of renal replacement therapy, yr
 22 to < 40168 (15.1)2 381 (12.3)< 0.001
 40 to < 60545 (49.0)5 434 (28.1)
 ≥ 60400 (35.9)11 548 (59.6)
Comorbidity
 Type 1 diabetes296 (26.6)3 140 (16.2)< 0.001
 Type 2 diabetes462 (41.5)3 510 (18.1)< 0.001
 Myocardial Infarction162 (14.6)3 889 (20.0)< 0.001
 Pulmonary edema355 (31.9)5 528 (28.5)0.02
 Stroke or TIA105 (9.4)2 042 (10.5)0.24
 Chronic lung disease85 (7.6)2 131 (11.0)< 0.001
 Peripheral vascular disease224 (20.1)3 595 (18.6)0.19
 Malignancy45 (4.0)1 854 (9.6)< 0.001
  • Note: TIA = transient ischemic attack.

  • * χ2 test.

  • Includes diabetes as a cause of end-stage renal disease and/or as a comorbidity.